Compare ZVRA & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | NBB |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 478.5M |
| IPO Year | 2015 | N/A |
| Metric | ZVRA | NBB |
|---|---|---|
| Price | $8.16 | $16.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.71 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 73.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.64% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $84,388,000.00 | N/A |
| Revenue This Year | $333.25 | N/A |
| Revenue Next Year | $43.70 | N/A |
| P/E Ratio | $15.50 | ★ N/A |
| Revenue Growth | ★ 244.60 | N/A |
| 52 Week Low | $6.19 | $13.67 |
| 52 Week High | $13.16 | $16.66 |
| Indicator | ZVRA | NBB |
|---|---|---|
| Relative Strength Index (RSI) | 36.63 | 42.89 |
| Support Level | $8.12 | $15.99 |
| Resistance Level | $9.03 | $16.32 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 3.63 | 21.79 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.